
17 Sep 2021
PANMURE: Faron Pharmaceuticals : ESMO data supports continuing development of bexmarilim
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: Faron Pharmaceuticals : ESMO data supports continuing development of bexmarilim
Faron Pharmaceuticals Oy (FARN:LON) | 212 -21.3 (-4.5%) | Mkt Cap: 237.9m
- Published:
17 Sep 2021 -
Author:
Dr Mike Mitchell | Dr Julie Simmonds -
Pages:
4 -